Hyaluronidase-nvhy
Generic Name: hyaluronidase-nvhy
Manufactured by BRISTOL-MYERS SQUIBB. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: NIVOLUMAB (600MG); HYALURONIDASE-NVHY (10000 UNITS PER 5ML(120MG/2000UNITS PER ML)). Application: BLA761429.
Overview
Manufactured by BRISTOL-MYERS SQUIBB. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: NIVOLUMAB (600MG); HYALURONIDASE-NVHY (10000 UNITS PER 5ML(120MG/2000UNITS PER ML)). Application: BLA761429.
Dosage
Available as injectable for injection use.
Related Medications
Nicardipine Hydrochloride
nicardipine hydrochloride
11 DESCRIPTION Nicardipine hydrochloride injection, USP is a calcium ion influx inhibitor (slow channel blocker or calcium channel blocker). Nicardipine hydrochloride injection, USP for intravenous administration contains 2.5 mg/mL of nicardipine hydrochloride.
Pomalidomide
pomalidomide
Thalidomide Analog [EPC]
11 DESCRIPTION Pomalidomide is a thalidomide analog. The chemical name is (RS)-4-Amino-2-(2,6-dioxo-piperidin-3-yl)-1H-isoindoline-1,3-dione and it has the following chemical structure: The molecular formula for pomalidomide is C 13 H 11 N 3 O 4 and the gram molecular weight is 273.24. Pomalidomide is a pale yellow to yellow color powder. Soluble in dimethylformamide and in dimethylsulfoxide.
Methyl Salicylate, Menthol, Unspecified Form, And Camphor (synthetic)
methyl salicylate, menthol, unspecified form, and camphor (synthetic)
Active Ingredients Purpose Methyl Salicylate 15% Topical Analgesic Menthol 5% Topical Analgesic Camphor 3% Topical Analgesic
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.